Hepatic artery infusion chemotherapy plus an immune checkpoint inhibitor and lenvatinib for the treatment of biliary tract carcinoma

The combination therapy of Gemox-HAIC with ICIs and lenvatinib shows promising efficacy and tolerable safety profiles in BTC patients.

Authors

Institutions

Publication Details

Journal
World Journal of Surgical Oncology
Published
2025-06-13
DOI
https://doi.org/10.1186/s12957-025-03882-3
Citations
1
Primary Topic
Cholangiocarcinoma and Gallbladder Cancer Studies
Type
article
Field-Weighted Citation Impact
2.01

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Hepatic artery infusion chemotherapy plus an immune checkpoint inhibitor and lenvatinib for the treatment of biliary tract carcinoma

Gao‐Jun Teng, Guangyu Zhu, Jin‐He Guo, Junying Wang
1 citations
World Journal of Surgical Oncology
Cholangiocarcinoma and Gallbladder Cancer Studies
2.01
article

Hepatic artery infusion chemotherapy plus an immune checkpoint inhibitor and lenvatinib for the treatment of biliary tract carcinoma

Gao‐Jun Teng, Guangyu Zhu, Jin‐He Guo, Junying Wang
article en
1 citations

Abstract

The combination therapy of Gemox-HAIC with ICIs and lenvatinib shows promising efficacy and tolerable safety profiles in BTC patients.

World Journal of Surgical OncologyVol. 23(1)
Zhongda Hospital Southeast University (CN)
Government of Jiangsu Province, Southeast University
Openalex Percentile: Top 15%
Cholangiocarcinoma and Gallbladder Cancer Studies
2.01
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.